0
Cortical Inhibition in Alcohol Dependence
Katherine H. Taber, Ph.D.; Robin A. Hurley, M.D.; Anissa Abi-Dargham, M.D.; Bernice Porjesz, M.D.
The Use of Herbal Alternative Medicines in NeuropsychiatryA Report of the ANPA Committee on Research
W. Curt LaFrance, Jr., M.D.; Edward C. Lauterbach, M.D.; C. Edward Coffey, M.D.; Stephen P. Salloway, M.D., M.S.; Daniel I. Kaufer, M.D.; Alison Reeve, M.D.; Donald R. Royall, M.D.; Elizabeth Aylward, Ph.D.; Teresa A. Rummans, M.D.; Mark R. Lovell, Ph.D.
The Role of the Cerebellum in Cognition and BehaviorA Selective Review
Mark Rapoport, M.D.; Robert van Reekum, M.D., F.R.C.P.C.; Helen Mayberg, M.D., F.R.C.P.C.
Orbital and Dorsolateral Frontal Perfusion Defect Associated With Behavioral Response to Cholinesterase Inhibitor Therapy in Alzheimer's Disease
Michael S. Mega, M.D., Ph.D.; Ivo D. Dinov, Ph.D.; Linda Lee, B.S.; Susan M. O'Connor, R.N.C.; Donna M. Masterman, M.D.; Barry Wilen, M.D.; Fred Mishkin, M.D.; Arthur W. Toga, Ph.D.; Jeffrey L. Cummings, M.D.
Medication-Induced Dystonias in Nine Patients With Dementia
Thomas M. Magnuson, M.D.; William H. Roccaforte, M.D.; Steven P. Wengel, M.D.; William J. Burke, M.D.
Sertraline in the Treatment of Major Depression Following Mild Traumatic Brain Injury
Jesse R. Fann, M.D., M.P.H.; Jay M. Uomoto, Ph.D.; Wayne J. Katon, M.D.
Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory
Daniel I. Kaufer, M.D.; Jeffrey L. Cummings, M.D.; Patrick Ketchel, M.Ed.; Vanessa Smith; Audrey MacMillan, C.R.N.P.; Timothy Shelley, M.S.W.; Oscar L. Lopez, M.D.; Steven T. DeKosky, M.D.
Discriminant Validity of the Wender Utah Rating Scale for Attention-Deficit/Hyperactivity Disorder in Adults
Barbara S. McCann, Ph.D.; Leonard Scheele, M.D.; Nicholas Ward, M.D.; Peter Roy-Byrne, M.D.
Relationship Between MRI Findings and Prognosis for Patients With General Paresis
Kazuhiro Kodama, M.D., Ph.D.; Shin-ichi Okada, M.D., Ph.D.; Naoya Komatsu, M.D., Ph.D.; Naoto Yamanouchi, M.D., Ph.D.; Shingo Noda, M.D.; Chikara Kumakiri, M.D., Ph.D.; Toshio Sato, M.D., Ph.D.
Cognitive Performance in Relation to MRI Temporal Lobe Volume in Schizophrenic Patients and Healthy Control Subjects
Lydia Krabbendam, M.A.; Mayke M. A. Derix, Ph.D.; Adriaan Honig, M.D., Ph.D., M.R.C.Psych.; Eric Vuurman, M.A.; Rob Havermans, M.D.; Jan T. Wilmink, Ph.D., M.D.; Jellemer Jolles, Ph.D.
Relationship of Cognitive Functioning, Adaptive Life Skills, and Negative Symptom Severity in Poor-Outcome Geriatric Schizophrenia Patients
Susan R. McGurk, Ph.D.; Patrick J. Moriarty, M.A.; Philip D. Harvey, Ph.D.; Michael Parrella, Ph.D.; Leonard White, Ph.D.; Joseph Friedman, M.D.; Kenneth L. Davis, M.D.
Late-Onset Obsessive-Compulsive DisorderA Case Series
Anthony P. Weiss, M.D.; Michael A. Jenike, M.D.
Acquired Obsessive-Compulsive Disorder Associated With Basal Ganglia Lesions
Ranjit C. Chacko, M.D.; Michael A. Corbin, M.D.; Robert G. Harper, Ph.D.
Clozapine in the Treatment of Mania
Detlef Degner, M.D.; Stefan Bleich, M.D.; Peter Müller, M.D.; Göran Hajak, M.D.; Lothar adler, M.D.; Eckart Rüther, M.D.
Treatment of Comorbid Bipolar Disorder and Epilepsy With Valproate
Donald M. Hilty, M.D.; Gerardo D. Rodriguez, M.D.; Robert E. Hales, M.D., M.B.A.
Imaging Auditory Verbal Hallucinations During Their Occurrence
Massoud Stephane, M.D.; Marshal Folstein, M.D.; Elisabeth Matthew, M.D.; Thomas C. Hill, M.D.
FDG-PET and IBZM-SPECT Suggest Reduced Thalamic Activity but No Dopaminergic Dysfunction in Chronic Alcohol Hallucinosis
Michael Soyka, M.D.; Thomas Zetzsche, M.D.; Stefan Dresel, M.D.; Klaus Tatsch, M.D.